Tecan and UgenTec partner to offer sample-to-result solutions for qPCR

Tecan and laboratory software specialist UgenTec have announced a collaboration to develop fully integrated, sample-to-result solutions for PCR workflows.

This newly formed partnership will combine Tecan’s liquid handling and automation expertise with UgenTec’s best-in-class FastFinder software, integrating end-to-end automation with comprehensive data analysis and workflow tools, providing high throughput solutions for molecular testing.

The COVID-19 pandemic has highlighted the challenges associated with high throughput molecular testing, requiring a more integrated approach to meet workload demands without compromising on the quality of results. Tecan and UgenTec will overcome this issue by creating a fully automated workflow – from sample preparation to data analysis and interpretation – using Tecan’s automation workstations with UgenTec’s FastFinder software suite. The joint solutions will be offered directly to diagnostics labs globally, as well as forming the basis of OEM in vitro diagnostics platforms developed through Tecan Synergence™.

This partnership with UgenTec is another important milestone in our growing digital ecosystem. We strongly believe that open innovation is the best way to provide labs with powerful solutions to meet the challenges they face today and to better prepare them for the future, and UgenTec’s forward-thinking approach and leading position in molecular diagnostics made the company a natural fit.”

Ralf Griebel, Head of Partnering Business at Tecan

Michiel Reessink, VP of Global Sales at UgenTec, added: “Efficient automation is now essential for molecular diagnostics labs to attain the throughput and traceability necessary to meet international quality and compliance standards. The combination of our diagnostics-oriented artificial intelligence tools with Tecan’s market-leading liquid handling technologies provides the perfect end-to-end solution, helping labs to achieve the accuracy and scalability required to address current and future challenges in molecular diagnostics.”

To learn more about Tecan’s offering in Genomics, visit diagnostics.tecan.com/molecular-genetics  

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Tecan. (2021, February 09). Tecan and UgenTec partner to offer sample-to-result solutions for qPCR. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20210209/Tecan-and-UgenTec-partner-to-offer-sample-to-result-solutions-for-qPCR.aspx.

  • MLA

    Tecan. "Tecan and UgenTec partner to offer sample-to-result solutions for qPCR". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20210209/Tecan-and-UgenTec-partner-to-offer-sample-to-result-solutions-for-qPCR.aspx>.

  • Chicago

    Tecan. "Tecan and UgenTec partner to offer sample-to-result solutions for qPCR". News-Medical. https://www.news-medical.net/news/20210209/Tecan-and-UgenTec-partner-to-offer-sample-to-result-solutions-for-qPCR.aspx. (accessed November 21, 2024).

  • Harvard

    Tecan. 2021. Tecan and UgenTec partner to offer sample-to-result solutions for qPCR. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20210209/Tecan-and-UgenTec-partner-to-offer-sample-to-result-solutions-for-qPCR.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The past, present and future of automation and digitalization in the life sciences laboratory